1. Home
  2. AVNW vs CCCC Comparison

AVNW vs CCCC Comparison

Compare AVNW & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aviat Networks Inc.

AVNW

Aviat Networks Inc.

HOLD

Current Price

$21.88

Market Cap

274.4M

Sector

Technology

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.57

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNW
CCCC
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
274.4M
240.3M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
AVNW
CCCC
Price
$21.88
$2.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$32.50
$8.50
AVG Volume (30 Days)
112.0K
1.7M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
$453,497,000.00
$30,108,000.00
Revenue This Year
$5.73
N/A
Revenue Next Year
$6.79
N/A
P/E Ratio
$20.97
N/A
Revenue Growth
10.72
N/A
52 Week Low
$15.80
$1.09
52 Week High
$26.83
$4.89

Technical Indicators

Market Signals
Indicator
AVNW
CCCC
Relative Strength Index (RSI) 48.99 51.91
Support Level $20.81 $2.49
Resistance Level $21.38 $2.84
Average True Range (ATR) 0.89 0.19
MACD 0.06 0.00
Stochastic Oscillator 56.81 52.72

Price Performance

Historical Comparison
AVNW
CCCC

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: